Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.54M
2: EX-4.6 Instrument Defining the Rights of Security Holders HTML 48K
6: EX-10.10 Material Contract HTML 47K
3: EX-10.5 Material Contract HTML 46K
4: EX-10.8 Material Contract HTML 47K
5: EX-10.9 Material Contract HTML 51K
7: EX-21.1 Subsidiaries List HTML 34K
8: EX-23.1 Consent of Expert or Counsel HTML 28K
9: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
10: EX-31.2 Certification -- §302 - SOA'02 HTML 33K
11: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
12: EX-32.2 Certification -- §906 - SOA'02 HTML 30K
18: R1 Cover Page HTML 97K
19: R2 Audit Information HTML 34K
20: R3 Condensed Consolidated Statements of Operations HTML 128K
and Comprehensive Income (Loss)
21: R4 Consolidated Balance Sheets HTML 138K
22: R5 Consolidated Balance Sheets (Parenthetical) HTML 49K
23: R6 Consolidated Statements of Stockholders' Equity HTML 127K
24: R7 Consolidated Statements of Cash Flows HTML 149K
25: R8 Organization and Nature of Operations HTML 32K
26: R9 Significant Accounting Policies HTML 101K
27: R10 Revenue HTML 57K
28: R11 Business Combinations HTML 44K
29: R12 Fair Value Measurements HTML 104K
30: R13 Allowance for Doubtful Accounts and Sales Reserves HTML 56K
31: R14 Property and Equipment HTML 42K
32: R15 Goodwill and Intangible Assets HTML 69K
33: R16 Convertible Senior Notes HTML 101K
34: R17 Accrued Payroll and Payroll-Related Liabilities HTML 35K
35: R18 Stockholders' Equity HTML 33K
36: R19 Equity Awards HTML 99K
37: R20 Retirement Plan HTML 35K
38: R21 Leases HTML 63K
39: R22 Commitments and Contingencies HTML 44K
40: R23 Income Taxes HTML 132K
41: R24 Basic and Diluted Net Income (Loss) Per Share HTML 58K
42: R25 Segment and Geographic Information HTML 42K
43: R26 Subsequent Event HTML 32K
44: R27 Significant Accounting Policies (Policies) HTML 148K
45: R28 Significant Accounting Policies (Tables) HTML 43K
46: R29 Revenue (Tables) HTML 50K
47: R30 Fair Value Measurements (Tables) HTML 98K
48: R31 Allowance for Doubtful Accounts and Sales Reserves HTML 54K
(Tables)
49: R32 Property and Equipment (Tables) HTML 43K
50: R33 Goodwill and Intangible Assets (Tables) HTML 75K
51: R34 Convertible Senior Notes (Tables) HTML 91K
52: R35 Accrued Payroll and Payroll-Related Liabilities HTML 35K
(Tables)
53: R36 Equity Awards (Tables) HTML 118K
54: R37 Leases (Tables) HTML 65K
55: R38 Commitments and Contingencies (Tables) HTML 43K
56: R39 Income Taxes (Tables) HTML 134K
57: R40 Basic and Diluted Net Income (Loss) Per Share HTML 60K
(Tables)
58: R41 Segment and Geographic Information Segment and HTML 37K
Geographic Information (Tables)
59: R42 Significant Accounting Policies - Additional HTML 68K
Information (Details)
60: R43 Significant Accounting Policies - Schedule of HTML 37K
Useful Lives by Asset Category (Details)
61: R44 Revenue - Disaggregation of Revenue (Details) HTML 49K
62: R45 Revenue - Contract Assets and Contract Liabilities HTML 58K
(Details)
63: R46 Revenue - Assets Recognized from the Costs to HTML 44K
Obtain Our Contracts with Customers (Details)
64: R47 Revenue - Remaining Performance Obligation HTML 41K
(Details)
65: R48 Business Combinations (Detail) HTML 120K
66: R49 Fair Value Measurements - Summary of Cash and Cash HTML 85K
Equivalents and Investments' Costs, Gross
Unrealized Losses, and Fair Value by Major
Security Type Recorded as Cash and Cash
Equivalents or Short-Term or Long-Term Investments
(Details)
67: R50 Fair Value Measurements - Additional Information HTML 41K
(Details)
68: R51 Allowance for Doubtful Accounts and Sales Reserves HTML 54K
(Details)
69: R52 Property and Equipment - Schedule of Property and HTML 46K
Equipment, Net (Details)
70: R53 Property and Equipment - Additional Information HTML 31K
(Details)
71: R54 Goodwill and Intangible Assets - Schedule of HTML 36K
Change in Carrying Amount of Goodwill (Details)
72: R55 Goodwill and Intangible Assets - Schedule of HTML 47K
Intangible Assets (Details)
73: R56 Goodwill and Intangible Assets - Schedule of HTML 36K
Intangible Asset Amortization Expense (Details)
74: R57 Goodwill and Intangible Assets - Schedule of HTML 45K
Finite-Lived Intangible Assets Estimated Remaining
Amortization Expense (Details)
75: R58 Convertible Senior Notes - Summary of Debt HTML 69K
(Details)
76: R59 Convertible Senior Notes - Additional Information HTML 103K
(Details)
77: R60 Convertible Senior Notes - Summary of Interest HTML 41K
Expense (Details)
78: R61 Convertible Senior Notes - Schedule Of Contractual HTML 38K
Obligations and Contractual Interest (Details)
79: R62 Accrued Payroll and Payroll-Related Liabilities HTML 34K
(Details)
80: R63 Stockholders' Equity (Details) HTML 56K
81: R64 Equity Awards - Additional Information (Details) HTML 105K
82: R65 Equity Awards - Schedule of Stock Option Activity HTML 83K
(Details)
83: R66 Equity Awards - Schedule of Weighted-average HTML 47K
Assumption Used for Stock Options (Details)
84: R67 Equity Awards - Schedule RSU Activity (Details) HTML 72K
85: R68 Equity Awards - Schedule of Stock-based HTML 41K
Compensation Expense (Details)
86: R69 Retirement Plan (Details) HTML 30K
87: R70 Leases - Lease-Related Assets and Liabilities HTML 39K
(Details)
88: R71 Leases - Lease Costs (Details) HTML 37K
89: R72 Leases - Supplemental Information (Details) HTML 33K
90: R73 Leases - Additional Information (Details) HTML 33K
91: R74 Leases - Undiscounted Cash Flows (Details) HTML 52K
92: R75 Commitments and Contingencies - Contractual HTML 42K
Obligations (Details)
93: R76 Commitments and Contingencies - Additional HTML 37K
Information (Details)
94: R77 Income Taxes - Components of Income (Loss) Before HTML 39K
Provision for (Benefit of) Income Taxes (Details)
95: R78 Income Taxes - Components of Provision for HTML 57K
(Benefit of) Income Taxes (Details)
96: R79 Income Taxes - Schedule of Provision for (Benefit HTML 54K
of) Income Taxes and Effective Tax Rates (Details)
97: R80 Income Taxes - Additional Information (Details) HTML 44K
98: R81 Income Taxes - Components of Deferred Income Tax HTML 78K
Assets (Liabilities) (Details)
99: R82 Income Taxes - Change in Valuation Allowance HTML 38K
(Details)
100: R83 Income Taxes - Schedule of Activity in Gross HTML 36K
Unrecognized Tax Benefits (Details)
101: R84 Basic and Diluted Net Income (Loss) Per Share - HTML 67K
Schedule of Computation of Net Income (Loss) per
Share (Details)
102: R85 Basic and Diluted Net Income (Loss) Per Share - HTML 49K
Weighted-average Equivalent Shares Excluded From
Diluted Net Income (Loss) per Share Calculation
(Details)
103: R86 Segment and Geographic Information Schedule of HTML 39K
Long-lived Assets Classified By Geographic
Location (Details)
104: R87 Subsequent Event - Additional Information (Detail) HTML 37K
107: XML IDEA XML File -- Filing Summary XML 192K
105: XML XBRL Instance -- ayx-20211231_htm XML 2.69M
106: EXCEL IDEA Workbook of Financial Reports XLSX 138K
14: EX-101.CAL XBRL Calculations -- ayx-20211231_cal XML 268K
15: EX-101.DEF XBRL Definitions -- ayx-20211231_def XML 807K
16: EX-101.LAB XBRL Labels -- ayx-20211231_lab XML 2.14M
17: EX-101.PRE XBRL Presentations -- ayx-20211231_pre XML 1.29M
13: EX-101.SCH XBRL Schema -- ayx-20211231 XSD 197K
108: JSON XBRL Instance as JSON Data -- MetaLinks 534± 791K
109: ZIP XBRL Zipped Folder -- 0001689923-22-000023-xbrl Zip 587K
Alteryx, Inc. (the “Company”) is pleased to offer you employment on the following terms:
1.Position. Your title will be Chief Revenue
Officer and you will report to the Company’s Chief Executive Officer. This is a full-time position. While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether full-time or part-time) that would create a conflict of interest with the Company or that would, directly or indirectly, constitute your engagement in or participation in any business that is competitive in any manner with the business of the Company. By signing this offer letter, you confirm to the Company that
you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company.
Upon successful execution of your FY21 objectives and the FY21 operating plan, your role will be evaluated for increased scope and responsibility.
2.Cash Compensation. The Company will pay you an annual base salary at the rate of $500,000 per year, payable in accordance with the Company’s standard payroll schedule. This compensation rate will be subject to adjustment pursuant to the
Company’s employee compensation policies in effect from time to time.
With your specific position, you will be eligible to receive a discretionary annual bonus of up to 100% of your base salary, based on both Company and individual performance, and in accordance with the Alteryx Standard Bonus Plan. For your first year of employment, we will guarantee a bonus payment of $500,000 which will be paid no later than January 15, 2022 (the timing of which will be a one-time exception to our annual bonus payment schedule which occurs normally in March of each year), subject to your continued employment with the Company in good standing. Please note that all discretionary bonus programs, payouts and criterion are subject to change or adjustment as the business or departmental needs at Alteryx may
require.
In addition, you will be paid a one-time signing bonus of $350,000 in connection with your employment with Alteryx, payable on the next scheduled payroll date immediately following the thirty (30) day period commencing the date you start working for the Company. If you resign for other than Good Reason prior to twelve (12) months of continuous service with the Company, this signing bonus will be repayable by you to the Company in full at the time of termination. You agree that the Company reserves the right to withhold any balance payable to the
Company from any form of compensation due to you, including salary, commissions, incentives, vacation time, buy-back of stock differentials and reimbursable expenses, except where prohibited by United States Federal or State law.
3.Employee Benefits. As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits to the extent that you comply with the eligibility requirements of each such benefit plan. You will receive a summary of such employee benefits. The Company, in its sole discretion, may amend, suspend or terminate its employee benefits at any time, with or without notice. In addition, you will be entitled to paid vacation
in accordance with the Company’s vacation policy, as in effect from time to time.
4.Equity. Subject to the approval of the Company’s Board of Directors and in accordance with the Company’s equity granting policy, you will be granted equity awards that will consist of a 50% / 50% combination of restricted stock units (the “RSU”) and non-qualified stock options (the “Option”), respectively, for shares of the Company’s Class A Common Stock, with an aggregate grant value of $10,000,000.
1
Exhibit
10.8
The RSU will be subject to the terms and conditions applicable to restricted stock units granted under the 2017 Equity Incentive Plan (the “Plan”), as described in the Plan, and the applicable Restricted Stock Unit Award Agreement. So long as your continuous Service (as defined in the Plan) status does not terminate, one-third of the total number of shares subject to RSU will vest on each of the first, second, and third annual anniversaries of the vesting commencement date (as set forth in the Restricted Stock Unit Award Agreement) (the “Vesting Commencement Date”).
The Option will be subject to the limitations set forth in the Plan and the Option Award Agreement, 1/3rd of the total number of shares subject to the Option Award shall vest and become exercisable on the one-year anniversary of the Vesting Commencement Date
and an additional 1/36th of the total number of shares subject to the Option Award shall vest and become exercisable on each monthly anniversary thereafter, subject to the your continued Service through each vesting date.
In addition, upon your employment, the Company and you will enter into a severance and change in control agreement in the form filed as Exhibit 10.1 to the Company’s Form 10-Q for the quarter ended March 31, 2020.
5.Confidential Information and Invention Assignment Agreement.
You will be required, as a condition of your employment with the Company, to sign the Company’s standard Confidential Information and Invention Assignment Agreement.
6.Mutual Arbitration Agreement. You will be required, as a condition of your employment with the Company, to sign the Company’s standard Mutual Arbitration Agreement.
7.No Conflicting Obligations. You represent
and warrant to the Company that you are under no obligations or commitments, whether contractual or otherwise, that are inconsistent with your obligations under this offer letter. You shall not use or disclose, in connection with your employment, any trade secrets or other proprietary information or intellectual property in which you or any other person has any right, title or interest and you confirm that your employment with the Company will not infringe or violate the rights of any other person. Also, we expect you to abide by any contractual obligations to refrain from soliciting any person employed by or otherwise associated with any former or current employer. You represent and warrant to the Company that
you have returned all property and confidential information belonging to any prior employer.
8.Verification of Information and Eligibility. This offer of employment is also contingent upon the successful verification of the information you provided to the Company during your application process, professional reference checks and a general background check performed by the Company to confirm your suitability for employment. By accepting this offer of employment, you warrant that all information provided by you is true and correct to the best of your knowledge, and you expressly release the
Company from any claim or cause of action arising out of the Company’s verification of such information. You have a right to review copies of any public records obtained by the Company in conducting this verification process unless you check the box below. Your offer is contingent upon the Company’s verification that you are permitted to legally work in the United States. You agree to provide the Company in a timely manner with any and all documentation reasonably necessary to confirm the foregoing.
9.At Will Employment
Relationship. Employment with the Company is for no specific period of time. Your employment with the Company will be “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause or notice. Any contrary representations that may have been made to you are superseded by this offer letter. This is the full and complete agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company’s
personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and the Company’s CEO.
2
Exhibit 10.8
10.Tax Matters.
(a)Withholding. All forms of compensation referred to in this offer letter are subject to reduction to reflect
applicable withholding and payroll taxes and other deductions required by law.
(b)Tax Advice. You are encouraged to obtain your own tax advice regarding your compensation from the Company. You agree that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or its Board of Directors related to tax liabilities arising from your compensation.
11.Interpretation, Amendment and Enforcement. This
offer letter, the Confidential Information and Invention Assignment Agreement, and the Mutual Arbitration Agreement constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior or contemporaneous agreements, representations or understandings (whether written, oral or implied) between you and the Company. This offer letter may not be amended or modified, except by an express written agreement signed by both you and a duly authorized officer of the Company. The terms of this offer letter and the resolution of any disputes as to the meaning, effect,
performance or validity of this offer letter or arising out of, related to, or in any way connected with, this offer letter, your employment with the Company or any other relationship between you and the Company (the “Disputes”) will be governed by California law, excluding laws relating to conflicts or choice of law. Except as otherwise set forth in the Mutual Arbitration Agreement, you and the Company submit to the exclusive personal jurisdiction of the federal and state courts located in Orange County, California in connection with any Dispute or any claim related to any Dispute.
* * * * *
We
are excited to have you join the Company. You may indicate your agreement with these terms and accept this offer by signing and dating the enclosed duplicate original of this offer letter, the enclosed Confidential Information and Invention Assignment Agreement, and the enclosed Mutual Arbitration Agreement, and returning them to Human Resources by close of business on 4/26/2021. Your employment is contingent upon you signing and returning the aforementioned documents and starting work in this new position as of 5/17/2021. As required by law, your employment with the Company is also contingent upon your providing legal proof of your identity and authorization to work in the United States.
If you have any questions, please
call me at .
Congratulations on your offer of employment! We are looking forward to you joining our team and the contributions we anticipate you making at Alteryx.
